The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Sidorov D.V.

City Clinical Oncology Hospital One Moscow City Healthcare Department

Grishin N.A.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Lozhkin M.V.

City Clinical Oncology Hospital One of the Moscow City Healthcare Department

Rubtsova N.A.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Volchenko N.N.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Troitsky A.A.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Stepanyuk I.V.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

Bykasov S.A.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

Peshkov A.O.

P.A. Herzen Moscow Oncology Research Institute of the Ministry of Health of the Russian Federation — Branch of the National Medical Radiology Research Center of the Ministry of Health of the Russian Federation

Moshurov R.I.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Reoperations in patients with pseudomyxoma peritonei

Authors:

Sidorov D.V., Grishin N.A., Lozhkin M.V., Rubtsova N.A., Volchenko N.N., Troitsky A.A., Stepanyuk I.V., Bykasov S.A., Peshkov A.O., Moshurov R.I.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2021;10(6): 14‑18

DOI: 10.17116/onkolog20211006114

Read: 1810 times

Download PDF (RU)
Contact the author
Table of contents

REOPERATIONS IN PATIENTS WITH PSEUDOMYXOMA PERITONEI
REOPERATIONS IN PATIENTS WITH PSEUDOMYXOMA PERITONEI

To cite this article:

Sidorov DV, Grishin NA, Lozhkin MV, et al. Reoperations in patients with pseudomyxoma peritonei. P.A. Herzen Journal of Oncology. 2021;10(6):14‑18. (In Russ.)
https://doi.org/10.17116/onkolog20211006114

Подписка 2026 Онкология. Журнал им. П.А. Герцена (P.A. Herzen Journal of Oncology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Refractory/relapsed primary mediastinal large B-cell lymphoma: a changing para­digm for drug therapy. P.A. Herzen Journal of Onco­logy. 2025;(4):107-116
Comparative asse­ssment of the onychomycosis phototherapy methods effi­cacy. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):313-318
Photodynamic and microcurrent therapy in reha­bilitation after facial plastic surgery. Plastic Surgery and Aesthetic Medi­cine. 2025;(2-2):65-68
Method of photodynamic action in surgical treatment of local limi­ted peri­tonitis in the expe­riment. Russian Journal of Operative Surgery and Clinical Anatomy. 2025;(2-2):77-86
Extracranial meta­stasis of WHO Grade I benign meni­ngioma: a clinical case and lite­rature review. Burdenko's Journal of Neurosurgery. 2025;(4):106-111
Treatment of cancer in tubu­lar villous colo­rectal adenomas. Piro­gov Russian Journal of Surgery. 2025;(9):29-35
Photodynamic therapy in comprehensive treatment of resi­stant forms of dermatomycosis caused by Trichophyton indo­tineae. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):489-494
Photodynamic therapy of skin cancer in transplant reci­pients. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):496-503
Inva­sive Treatment of Recu­rrent Vari­cose Veins in Patients with Femo­ral Vein Inco­mpetence. Journal of Venous Diso­rders. 2025;(3):156-163
Pathology features of recu­rrent meni­ngioma. Russian Journal of Archive of Pathology. 2025;(5):28-35
Abstract:

OBJECTIVE

To identify predictors of recurrent pseudomyxoma after cytoreductive surgery and to justify the effectiveness of their repetitions.

SUBJECTS AND METHODS

The paper presents the results of 20 reoperations in 13 (15.3%) patients with recurrence or progression of pseudomyxoma peritonei. To identify predictors of disease recurrence, the authors analyze the features of the first cytoreductive operation, such as peritoneal cancer index; complete cytoreduction score; use of one or another antitumor agent; tumor morphopathogical features.

RESULTS

Clavien—Dindo grades 2—3 postoperative complications developed in 3 (23.1%) patients; in-hospital deaths were absent. The overall survival of patients after reoperation was 51.1 months; the progression-free period was 35.8 months. Early disease continuation during the first 2 years was recorded in 5 (38.5%) patients.

CONCLUSION

The findings suggest that cytoreductive operations, including repeated ones, are safe and effective.

Keywords:

pseudomyxoma peritonei
completeness of cytoreduction
progression
recurrence
photodynamic therapy
hyperthermic chemotherapy
relapse-free period

Authors:

Sidorov D.V.

City Clinical Oncology Hospital One Moscow City Healthcare Department

Grishin N.A.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Lozhkin M.V.

City Clinical Oncology Hospital One of the Moscow City Healthcare Department

Rubtsova N.A.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Volchenko N.N.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Troitsky A.A.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Stepanyuk I.V.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

Bykasov S.A.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

Peshkov A.O.

P.A. Herzen Moscow Oncology Research Institute of the Ministry of Health of the Russian Federation — Branch of the National Medical Radiology Research Center of the Ministry of Health of the Russian Federation

Moshurov R.I.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Received:

27.07.2021

Accepted:

16.08.2021

Close metadata

References:

  1. Mercier F, Dagbert F, Pocard M, et al. Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. BJS Open. 2018;3(2):195-202.  https://doi.org/10.1002/bjs5.97
  2. Horvath Ph, Yurttas C, Birk Ph,et al. Cellularity in low-grade Pseudomyxoma peritonei impacts recurrence-free survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Langenbecks. Arch Surg. 2018;403(8):985-990.  https://doi.org/10.1007/s00423-018-1735-5
  3. Chua TC, Liauw W, Morris DL. Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome. Int J Colorectal Dis. 2012;27(3):381-389.  https://doi.org/10.1007/s00384-011-1303-8
  4. Guaglio M, Sinukumar S, Kusamura S, et al. Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective Series. Ann Surg Oncol. 2018;25(4):878-884.  https://doi.org/10.1245/s10434-017-6305-5
  5. Ma RQ, Xia A, Zhai XC, Chen F, Xu HB. A single-center clinical analysis of 65 cases of pseudomyxoma peritonei from appendiceal origin in the early stage. Zhonghua Zhong Liu Za Zhi. 2019;41(9):698-702.  https://doi.org/10.3760/cma.j.issn.0253-3766.2019.09.010
  6. Lord AC, Shihab O, Chandrakumaran K, et al. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours. Eur J Surg Oncol. 2015;41(3):396-399.  https://doi.org/10.1016/j.ejso.2014.08.476
  7. van Eden WJ, Kok NFM, Snaebjornsson P, et al. Factors influencing long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms. BJS Open. 2019;3(3):376-386.  https://doi.org/10.1002/bjs5.50134
  8. Solomon D, Bekhor E, Leigh N, et al. Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite Experience. Ann Surg Oncol. 2020;27(1):147-153.  https://doi.org/10.1245/s10434-019-07678-0
  9. Huang R, Xiu-Ling Shi, Yun-Fei Wang, et al. Apatinib for treatment of a pseudomyxoma peritonei patient after surgical treatment and hyperthermic intraperitoneal chemotherapy: A case report. World J Clin Cases. 2019;7(22):3881-3886. https://doi.org/10.12998/wjcc.v7.i22.3881
  10. Jarvinen P, Ristimaki A, Kantonen J, et al. Comparison of serial debulking and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in pseudomyxomaperitonei of appendiceal origin. Int J Colorectal Dis. 2014;29:999-1007. https://doi.org/10.1007/s00384-014-1933-8
  11. Hegg KS, Mack LA, Bouchard-Fortier A, et al. Macroscopic and microscopic characteristics of low grade appendiceal mucinous neoplasms (LAMN) on appendectomy specimens and correlations with pseudomyxoma peritonei development risk. Ann Diagn Pathol. 2020;48:151606. https://doi.org/10.1016/j.anndiagpath.2020.151606
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.